Importer of Controlled Substances Application: Noramco, 97071 [2024-28728]

Download as PDF Federal Register / Vol. 89, No. 235 / Friday, December 6, 2024 / Notices Carolina 29418–8305, applied to be registered as an importer of the following basic class(es) of controlled substance(s): Controlled substance Marihuana Extract ........... Marihuana ........................ Tetrahydrocannabinols .... Psilocybin ........................ Psilocyn ........................... The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on October 9, 2024, Noramco, 500 Swedes Landing Road, Wilmington, Delaware 19801–4417, applied to be registered as an importer of the following basic class(es) of controlled substance(s): ADDRESSES: Drug code Schedule 7350 7360 7370 7437 7438 I I I I I The company plans to import the listed controlled substances to produce analytical reference standards for sale and distribution to its customers. Drug codes 7350 (Marihuana Extract) and 7360 (Marihuana) will be used for the manufacture of cannabidiol only. In reference to drug code 7370 (Tetrahydrocannabinols) the company plans to import a synthetic version of this controlled substance. No other activities for these drug codes are authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2024–28717 Filed 12–5–24; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Controlled substance Drug code Schedule 2010 I 7360 7370 9254 9600 9610 9620 9630 9639 9640 9650 I I II II II II II II II II 9668 9670 9780 II II II Drug Enforcement Administration [Docket No. DEA–1462] Importer of Controlled Substances Application: Noramco Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Noramco has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before January 6, 2025. Such persons may also file a written request for a hearing on the application on or before January 6, 2025. lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 18:02 Dec 05, 2024 Jkt 265001 Gamma Hydroxybutyric Acid. Marihuana ........................ Tetrahydrocannabinols .... Methadone-Intermediate Opium, Raw ..................... Opium Extracts ................ Opium Fluid Extract ......... Opium Tincture ................ Opium, Powdered ............ Opium, Granulated .......... Opium Poppy/Poppy Straw. Noroxymorphone ............. Poppy Straw Concentrate Tapentadol ...................... The company plans to import Poppy Straw Concentrate (9670) to bulk manufacture other controlled substances for distribution to its customers. The company plans to import an intermediate form of Tapentadol (9780) to bulk manufacture Tapentadol for distribution to its customers. In reference to drug codes 7360 PO 00000 Frm 00136 Fmt 4703 Sfmt 4703 97071 (Marihuana) and 7370 (Tetrahydrocannabinols), the company plans to import a synthetic cannabidiol and a synthetic Tetrahydrocannabinol. No other activities for these drug codes are authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration approved or nonapproved finished dosage forms for commercial sale. Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2024–28728 Filed 12–5–24; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Notice of Lodging of Proposed Consent Decree Under the Clean Air Act On December 2, 2024, the Department of Justice lodged a proposed Consent Decree with the United States District Court for the Western District of Missouri in the lawsuit entitled United States of America v. BCP Ingredients, Inc. Civ. No. 3:24–cv–5094 (W.D. Mo.). The Complaint seeks injunctive relief and civil penalties for alleged violations of section 112(r) of the Federal Clean Air Act (‘‘CAA’’), 42 U.S.C. 7412(r)(7), and its implementing regulations set forth at 40 CFR part 68, resulting from a release of ethylene oxide (‘‘EtO’’) at a chemical manufacturing and repackaging facility owned and operated by BCP Ingredients, Inc. (‘‘BCP’’) in Verona, Missouri. Under the proposed Consent Decree resolving these alleged violations, BCP will pay a civil penalty of $300,000 to the United States, install an additional state-of-the-art EtO scrubber to reduce EtO emissions at its facility, and share a copy of its final audit completion report from a 2022 third party audit. BCP also will be required to perform three Supplemental Environmental Projects totaling $350,000: (1) donation of two vehicles to a local healthcare provider to provide mobile health services to communities near BCP’s facility; (2) provision of at least 1,000 medical visits to be administered by the same local healthcare provider using the vehicles BCP will donate for the first SEP; and (3) donation of emergency response equipment to a fire department near BCP’s facility. The publication of this notice opens a period for public comment on the proposed Consent Decree. Comments E:\FR\FM\06DEN1.SGM 06DEN1

Agencies

[Federal Register Volume 89, Number 235 (Friday, December 6, 2024)]
[Notices]
[Page 97071]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-28728]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1462]


Importer of Controlled Substances Application: Noramco

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Noramco has applied to be registered as an importer of basic 
class(es) of controlled substance(s). Refer to Supplementary 
Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants, therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
January 6, 2025. Such persons may also file a written request for a 
hearing on the application on or before January 6, 2025.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment. All 
requests for a hearing must be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152. All requests for a hearing should also be 
sent to: Drug Enforcement Administration, Attn: Administrator, 8701 
Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on October 9, 2024, Noramco, 500 Swedes Landing Road, 
Wilmington, Delaware 19801-4417, applied to be registered as an 
importer of the following basic class(es) of controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid...............    2010  I
Marihuana...............................    7360  I
Tetrahydrocannabinols...................    7370  I
Methadone-Intermediate..................    9254  II
Opium, Raw..............................    9600  II
Opium Extracts..........................    9610  II
Opium Fluid Extract.....................    9620  II
Opium Tincture..........................    9630  II
Opium, Powdered.........................    9639  II
Opium, Granulated.......................    9640  II
Opium Poppy/Poppy Straw.................    9650  II
Noroxymorphone..........................    9668  II
Poppy Straw Concentrate.................    9670  II
Tapentadol..............................    9780  II
------------------------------------------------------------------------

    The company plans to import Poppy Straw Concentrate (9670) to bulk 
manufacture other controlled substances for distribution to its 
customers. The company plans to import an intermediate form of 
Tapentadol (9780) to bulk manufacture Tapentadol for distribution to 
its customers. In reference to drug codes 7360 (Marihuana) and 7370 
(Tetrahydrocannabinols), the company plans to import a synthetic 
cannabidiol and a synthetic Tetrahydrocannabinol. No other activities 
for these drug codes are authorized for this registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration approved or non-approved finished 
dosage forms for commercial sale.

Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2024-28728 Filed 12-5-24; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.